Anti-cancer activity elucidation of geissolosimine as an MDM2-p53 interaction inhibitor: An in-silico study.Published in:PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0323003By:Al-Amin, Md.;Tanjin, Rehnuma;Karim, Md. Rasul;Etee, Jannatul Mawa;Siddika, Ayesha;Akter, Nafisa;Uddin, Md. Helal;Mahmud, Ratul;Saffat, Tasfia;Hossen, Md. Faruk;Mowlee, Samira Idris;Rafa, Elmu Kabir;Akter, SumiPublication type:Article